Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07463781) titled 'Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy' on Feb. 24.
Study Type: Observational
Primary Sponsor: Fondazione Italiana Linfomi - ETS
Condition:
Diffuse Large B Cell Lymphoma (DLBCL)
High Grade B Cell Lymphoma
Primary Mediastinal B-cell Lymphoma (PMBCL)
Intervention:
Other: Chimeric Antigen Receptor T-cells (CAR-T) therapy
Recruitment Status: Not recruiting
Date of First Enrollment: May 2026
Target Sample Size: 100
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07463781
Published by HT Digital Content Services with permission f...